Biology 11mrs. N. Gill

Hematology

Hinojosa L, Kumar N, Gill KS, Murphy KM (2019) Spectral reflectance indices and physiological parameters in quinoa under different irrigation regimes. Crop Science 59(5):1927. Kumar N, Kiszonas A, Ibba MI, Morris CF (2019) Identification of molecular markers associated with super soft kernel texture in wheat. A gill (/ ɡ ɪ l / ) is a respiratory organ found in many aquatic organisms that extracts dissolved oxygen from water and excretes carbon dioxide.The gills of some species, such as hermit crabs, have adapted to allow respiration on land provided they are kept moist.

FullPhiladelphia, PA

Myeloproliferative Disorder Hematology-Oncology

Physician

Dr. Gillis on Doximity

Wonderware license server. As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits
  • 3400 Civic Center Boulevard
    Philadelphia, PA 19104

Education & Training

  • University of Melbourne Faculty of MedicineClass of 1999

Certifications & Licensure

Clinical Trials

  • CD123 Redirected Autologous T Cells for AMLStart of enrollment: 2015 Dec 01Saar Gill, MD, PhD
  • Pilot Trial Of Autologous T Cells Engineered To Express Anti-CD19 Chimeric Antigen Receptor (CART19)In Combination With Ibrutinib In Patients With Relapsed Or Refractory CD19+ Chronic Lymphocytic Leukemia (CLL)Or Small Lymphocytic Lymphoma (SLL)Start of enrollment: 2015 Dec 01Saar Gill, MD

Biology 11 Mrs N Gill Full

Publications & Presentations

PubMed

  • Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
    Brian Ball, Christopher Famulare, Eytan M. Stein, Martin S. Tallman, Andriy Derkach, Mikhail Roshal, Saar Gill, Benjamin M Manning, Jamie L. Koprivnikar, James K. McCl..> ;Blood Advances. 2020 Jul 14
  • Cancer immunotherapy comes of age and looks for maturity.
    Finck, A., Gill, S. I., June, C. H.> ;Nature communications. 2020 Jul 6
  • Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation.
    Craig W. Freyer, Alison Carulli, Alex Ganetsky, Mitchell E. Hughes, Tracy M. Krause, Colleen Timlin, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Alison W. Loren, J..> ;Leukemia & Lymphoma. 2020 Jun 1

Journal Articles

Biology 11 Mrs N Gill Unit

  • Novel Approaches to Acute Myeloid Leukemia Immunotherapy
    Saar Gill, MD, Clinical Cancer Research

Abstracts/Posters

  • Combined Venetoclax and Hypomethylating Agent (HMA) Therapy Induces High Response Rates in Patients with Myelodysplastic Syndrome Including Patients Previously Failing..
    Saar I. Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Identification and Validation of Predictive Biomarkers to CD19- and BCMA-Specific CAR T-Cell Responses in CAR T-Cell Precursors
    Saar Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Single Chain Variable Fragment Linker Length Regulates CAR Biology and T Cell Efficacy
    Saar I. Gill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Career-Development Lunch Sessions: Adult Clinical Malignant Hematology/BMT
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Biology 11 Mrs N Gillespie

Press Mentions

Mrs

Biology 11 Mrs N Gill -

  • Marrow Clearance with Concurrent CAR T-cells, Ibrutinib in Resistant CLLOctober 24, 2020 18:55
  • CAR Macrophages Go Beyond T Cells to Fight Solid TumorsMarch 24, 2020 09:37
  • First-of-Its-Kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer ModelsMarch 24, 2020 09:37

Hospital Affiliations

  • Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
  • UPMC PresbyterianPittsburgh, Pennsylvania

Dr. Saar Gill, Dr. Saar Gill, MD, Dr. S Gill, Dr. Saar I Gill